| Agatha Jassem | |
| Nationality: | Canadian |
| Alma Mater: | University of British Columbia |
| Occupation: | clinical microbiologist |
Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory,[1] and a clinical assistant professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada.[2]
Jassem obtained her PhD at the University of British Columbia, followed by a fellowship in Clinical Microbiology at the National Institutes of Health.[3] Her research focuses the detection of healthcare-and community-associated infections, emerging pathogens, and drug resistance determinants.
During the COVID-19 pandemic response, Jassem led research efforts on COVID-19 breakthrough infections from vaccinated individuals,[4] [5] SARS-CoV-2 population level seroprevalence,[6] antibody response [7] as well as collaborating on research on securing reagents for COVID-19 during world-wide shortages,[8] and the role of ACEII. [9]